Coloplast A/S (OTCMKTS:CLPBY) Trading Down 2.3% – Here’s Why

Shares of Coloplast A/S (OTCMKTS:CLPBY) traded down 2.3% on Thursday . The company traded as low as $11.49 and last traded at $11.49. 216,857 shares were traded during mid-day trading, an increase of 70% from the average session volume of 127,904 shares. The stock had previously closed at $11.76.

Analyst Ratings Changes

Separately, Hsbc Global Res upgraded Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research note on Monday, November 18th.

Coloplast A/S Trading Down 2.3 %

The company has a debt-to-equity ratio of 1.00, a current ratio of 0.85 and a quick ratio of 0.56. The stock has a 50-day simple moving average of $12.76 and a 200-day simple moving average of $12.86.

Coloplast A/S (OTCMKTS:CLPBY) last posted its earnings results on Tuesday, November 5th. The company reported $0.08 earnings per share for the quarter. The firm had revenue of $1.02 billion for the quarter. Coloplast A/S had a net margin of 18.69% and a return on equity of 31.17%. As a group, equities analysts anticipate that Coloplast A/S will post 0.37 earnings per share for the current fiscal year.

Coloplast A/S Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, December 20th. Shareholders of record on Monday, December 9th will be issued a $0.2435 dividend. The ex-dividend date is Monday, December 9th. This is a boost from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s dividend payout ratio is presently 27.27%.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.